SL-401 as Consolidation Therapy in Patients With Adverse Risk Acute Myeloid Leukemia in First Complete Remission
Clinical trial NCT02270463 · TERMINATED
Trial details
- NCT number
- NCT02270463
- Sponsor
- Stemline Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2019-12-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.